Bay Street News, February 5th, 2024

Company is initiating its pivotal multicenter, prospective, randomized CLARITY trial to build on clinical evidence demonstrating superior surgical outcomes when […]

MINNETONKA, Minn., Feb. 05, 2024 (GLOBE NEWSWIRE) — Pineapple Energy Inc. (NASDAQ: PEGY) (“Pineapple” or the “Company”), a leading provider […]

—  Data served as foundation for current vaccine candidate for planned Phase 2 research —  Vaxart vaccine candidates elicited strong antigen-specific serum […]

Approaching 6 anticipated data readouts across 3 platforms in 2024, including survival data in non-small cell lung cancer (NSCLC) and […]

MILTON, N.Y., Feb. 05, 2024 (GLOBE NEWSWIRE) — Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, […]

FARMINGTON HILLS, Mich., Feb. 05, 2024 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused […]

SAINT LAURENT, Quebec, Feb. 05, 2024 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) today announced positive results [...]

RIMOUSKI, Quebec, Feb. 05, 2024 (GLOBE NEWSWIRE) — Puma Exploration Inc. (TSX-V: PUMA, OTCQB: PUMXF) (the “Company” or “Puma”) is […]

BELGRADE, Mont., Feb. 05, 2024 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company […]

VANCOUVER, British Columbia, Feb. 05, 2024 (GLOBE NEWSWIRE) — Greenridge Exploration Inc. (“Greenridge” or the “Company”) (CSE: GXP | FRA: […]